A drug screening specialist saw a huge rise in profits during the pandemic, helped by government Covid testing contracts.
Derby-based SureScreen Diagnostics reported pre-tax profits of £67.2 million in the year to May 31, 2021, compared to £900,000 the year before. Newly filed Companies House accounts showed turnover for the year when the pandemic was at its height stood at £148.1 million – up from £6.7 million the year before.
The business was one of many around the UK to strike big deals with the Government as Downing Street pumped billions of pounds of taxpayer cash into trying to get to grips with the coronavirus. SureScreen also sold lateral flow tests to more than 60 countries worldwide, while closer to home its tests were rolled out to universities across England.
